sb 203580 has been researched along with lavendustin a in 1 studies
| Studies (sb 203580) | Trials (sb 203580) | Recent Studies (post-2010) (sb 203580) | Studies (lavendustin a) | Trials (lavendustin a) | Recent Studies (post-2010) (lavendustin a) |
|---|---|---|---|---|---|
| 3,489 | 4 | 1,137 | 174 | 0 | 5 |
| Protein | Taxonomy | sb 203580 (IC50) | lavendustin a (IC50) |
|---|---|---|---|
| Estrogen receptor beta | Mus musculus (house mouse) | 8 | |
| Epidermal growth factor receptor | Homo sapiens (human) | 4.1 | |
| Tyrosine-protein kinase Lck | Homo sapiens (human) | 8 | |
| Estrogen receptor | Mus musculus (house mouse) | 8 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bullock, AN; Fedorov, O; Knapp, S; Marsden, B; Müller, S; Pogacic, V; Rellos, P; Schwaller, J; Sundström, M | 1 |
1 other study(ies) available for sb 203580 and lavendustin a
| Article | Year |
|---|---|
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
Topics: Amino Acid Sequence; Binding Sites; Clinical Trials as Topic; Drug Evaluation, Preclinical; Enzyme Stability; Humans; Molecular Sequence Data; Phylogeny; Protein Array Analysis; Protein Conformation; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases | 2007 |